Retatrutide vs Tirzepatide: 89-Week Obesity Trial Nears Completion | Retatrutide News

A clinical trial is comparing retatrutide and tirzepatide in adults with obesity over 89 weeks. The study is active but not recruiting, focusing on effi...
Clinical Trials · October 11, 2026